Schedule 13D ownership disclosure
Tribute Pharmaceuticals Canada Inc.
Security class unavailable · CUSIP: 89609J106
Event date: 2011-12-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001354488-15-001228
- Form type
- SC 13D
- Filer
- Harris Robert Paul
- CIK
- CIK 1537250
- Filed
- Mar 18, 2015
- Reporting period
- Dec 01, 2011
- Description
- Schedule 13D beneficial ownership